Osmopharm is a Swiss pharmaceutical Company. Created in 1994, it is specialised in modified release systems for oral drugs, based on the application of some of the more advanced galenic technologies.

Osmopharm's major activity is the production under contract manufacturing by following the more strict GMP rules assured by Swissmedic and by prestigeous pharmaceutical companies inspection.

Its  technical management, with about 40 years of experience, can study and develop new products offering to the costumers a global support for new registrations and/or for actualizing the existing ones by according to regulatory requirements.

Osmopharm staff is composed by about 100 persons that, in order to meet the customers expectations, is under a continuous challenge for studying new technologies and formulations and to maintain the highest Quality Levels.